Sometimes clinical trials are terminated while on going.   This is always sad for me, but it is important to keep track of the failures and ...

Back in April, I blogged about a Phase-II study called "Anti-Thymocyte Globulin and Verapamil Start A Phase-2 Clinical Trial" (NCT06455319)....

A new clinical trial is testing Rezpegaldesleukin, also known as NKTR-358, or REZPEG, as a potential treatment to slow or stop T1D in honeym...

Researchers at the University of Florida are launching a new Phase 2 clinical trial to evaluate a combination therapy for individuals recent...

Researchers at the University of Miami are exploring whether a combination of two well-known supplements—omega-3 fatty acids and vitamin D—m...

An open letter to everyone who cares about research aimed at type 1 diabetes cures. I've been blogging on research aimed at curing type 1 di...

A new clinical trial is exploring whether two different immune therapies, used alone or in combination, can delay or prevent the onset of  T...

The Fecal Autologous Capsule Transplantation for Type 1 Diabetes Mellitus (FACT-T1D) trial is testing a new approach to treating or curing t...

Levi’s Stadium’s projected game schedule is a who’s who of “who?”

CNK-UT009, as tested here, is a one-time infusion of living cells designed to modify the immune system’s behavior.  The idea behind it is th...

Learn about teas straight from local and global producers at the Ferry Building in San Francisco. Free swag bag includes your very own teacup to savor tea.

IMMUNOSTEM technology refers to using a virus (specifically a lentivirus) to deliver a new gene into cells, which will then produce a specif...

Baricitinib works by interfering with signaling pathways inside immune cells, to reduce inflammation and lower the immune system.  It is par...

This blog posting reports on the results of Avotres recent phase-I clinical trial into AVT001 and the company's future plans for testing.  I...

This clinical trial tested whether long-term daily treatment with Remygen®, an oral drug developed by Diamyd Medical, could help restore ins...

This blog post reports on some news that I consider exciting, for at least two different reasons: first because it might be an early milesto...

TIX100 is a protein which inhibits the action of TIXNP (thioredoxin-interacting protein).  It is being developed by the TIXIMED company.  TX...

This is the most fun I have had writing a blog in a long time.  It is not often I can blog about psychedelics and curing type-1 diabetes at ...

With DeepSeek shaking up the AI world, SFGATE columnist Drew Magary asked its competitors a bunch of dumb questions, and got very dumb answers.

Denosumab is a monoclonal antibody, which is already approved for several bone related diseases and is sold under the names Wyost, Xgeva, Pr...

Meet Evie, a college senior who’s a master at both online role-playing and real-life ghostwriting -- her side hustle is writing love letters for other people. But she’s navigating the complexities of ...

Normally, sometime in October, I write a summary of all the clinical trials funded by JDRF.   However, this year I didn't, which was a mista...

Fenofibrate (also spelled Phenofibrate) is commonly prescribed for high cholesterol and high triglycerides. In 2017, it was the 70th most co...

The company Encellin has started a Phase-I clinical trial to test ENC-201-CED an encapsulated beta cell product. Encapsulated Beta Cells In ...

There are two good reasons to test Frexalimab as a cure or treatment for Type-1 Diabetes (T1D).  The first is that it has shown some effecti...